Data / Drug companies / PuraCap Pharmaceutical LLC
PuraCap Pharmaceutical LLC: 21 products in the FDA NDC directory, labeler code 51013
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
PuraCap Pharmaceutical LLC (labeler code 51013) lists 21 products in the FDA National Drug Code Directory, covering 9 finished drugs by generic name. By type: 21 over the counter drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on March 12, 2025.
The request: Watch PuraCap Pharmaceutical LLC (FDA labeler code 51013): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 51013
- Products in commercial distribution
- 21
- Packages
- 37
- Finished drugs by generic name
- 9
- Prescription products
- 0
- Over the counter products
- 21
- Flagged as original packager
- 21 of 21 products that carry the flag
- Started marketing in the last 12 months
- 0
- Earliest marketing start
- June 9, 2016
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 13 | 61.9% |
| Generic drugs (ANDA) | 8 | 38.1% |
Products by type
| Type | Products | Share |
|---|---|---|
| Over the counter drugs | 21 | 100% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Ibuprofen | 7 | 190 |
| Acetaminophen, dextromethorphan hydrobromide | 2 | 20 |
| Naproxen sodium | 1 | 100 |
| Bismuth subsalicylate | 1 | 80 |
| Meclizine hcl | 1 | 32 |
| Diphenhydramine hcl 50mg | 1 | 3 |
| Acetaminophen | 1 | 214 |
| Calcium carbonate | 1 | 101 |
| Docusate sodium 100mg | 1 | 3 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Capsule, liquid filled | 15 | 71.4% |
| Tablet, chewable | 3 | 14.3% |
| Tablet | 1 | 4.8% |
| Kit | 1 | 4.8% |
| Tablet, film coated | 1 | 4.8% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Ultra Concentrated Nighttime COLD AND FLU | 51013-668 | Capsule, liquid filled | Over the counter monograph drugs | March 12, 2025 |
| Ultra Concentrated Daytime COLD AND FLU | 51013-667 | Capsule, liquid filled | Over the counter monograph drugs | March 12, 2025 |
| Daytime COLD AND FLU | 51013-666 | Capsule, liquid filled | Over the counter monograph drugs | March 12, 2025 |
| Stool Softener | 51013-819 | Capsule, liquid filled | Over the counter monograph drugs | November 30, 2024 |
| Nighttime SLEEP AID | 51013-817 | Capsule, liquid filled | Over the counter monograph drugs | November 30, 2024 |
| Naproxen sodium | 51013-137 | Capsule, liquid filled | Generic drugs (ANDA) | March 20, 2018 |
| Ibuprofen | 51013-429 | Capsule, liquid filled | Generic drugs (ANDA) | February 13, 2018 |
| Extra Strength Antacid | 51013-323 | Tablet, chewable | Over the counter monograph drugs | December 13, 2017 |
| Motion Sickness Relief | 51013-322 | Tablet, chewable | Over the counter monograph drugs | November 28, 2017 |
| Stomach Relief | 51013-321 | Tablet, chewable | Over the counter monograph drugs | November 28, 2017 |
| Extra Strength Acetaminophen | 51013-320 | Tablet, film coated | Over the counter monograph drugs | November 9, 2017 |
| Ibuprofen | 51013-319 | Tablet | Generic drugs (ANDA) | November 9, 2017 |
| Ibuprofen | 51013-422 | Capsule, liquid filled | Generic drugs (ANDA) | November 1, 2017 |
| Ibuprofen | 51013-421 | Capsule, liquid filled | Generic drugs (ANDA) | August 29, 2017 |
| Ibuprofen | 51013-410 | Capsule, liquid filled | Generic drugs (ANDA) | July 14, 2017 |
| Ibuprofen | 51013-405 | Capsule, liquid filled | Generic drugs (ANDA) | July 14, 2017 |
| Ibuprofen | 51013-103 | Capsule, liquid filled | Generic drugs (ANDA) | October 12, 2016 |
| Severe Sinus Congestion Allergy and Cough Formula | 51013-169 | Capsule, liquid filled | Over the counter monograph drugs | June 29, 2016 |
| DG Day Time Cold and Flu Formula and Night Time Cold and Flu Formula | 51013-168 | Kit | Over the counter monograph drugs | June 15, 2016 |
| Daytime Severe Cold and Flu Relief | 51013-174 | Capsule, liquid filled | Over the counter monograph drugs | June 13, 2016 |
| Night Time Severe Cold and Flu Relief | 51013-175 | Capsule, liquid filled | Over the counter monograph drugs | June 9, 2016 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.